Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News MindBio Therapeutics Corp. C.MBIO

Healthcare Biotechnology
MindBio Therapeutics Corp is a pioneering clinical stage biotechnology company that specializes in developing psychedelic microdosing treatments for mental health conditions. MindBio has obtained government and regulatory approvals for at-home LSD microdosing in clinical trials, making it the only organization in the world to do so.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:MBIO)

Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders

Business Wire 4 days ago

MindBio Therapeutics Scientists Present Landmark Women's Health Trials. Company To Release Phase 2A Depression Trial Secondary Data This Month

Accesswire May 2, 2024

MindBio Is Exploring Dual Listing on A Senior Exchange with Multiple Phase 2B Clinical Trials Underway Supported by Positive Trial Data and Planning for Phase 3

Accesswire May 1, 2024

MindBio Therapeutics Announces Landmark Women's Health CNS Drug Trials

Accesswire April 30, 2024

MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry

Accesswire April 23, 2024

Lender Requests to Convert Loan to MindBio Shares

Accesswire April 16, 2024

Psychedelic stock begins take-home LSD microdosing clinical trial

Jonathon Brown March 20, 2024

MindBio Begins Landmark Phase 2B Take-Home Microdosing (MB22001) Clinical Trial in Patients with Major Depressive Disorder

Accesswire March 20, 2024

MindBio Therapeutics Receives Final Regulatory Approval to Conduct Phase 2B Randomised Controlled Trial Microdosing Mb22001 in Patients Diagnosed with Major Depressive Disorder

Accesswire March 4, 2024
View More News ››

Opinion & Analysis (CSE:MBIO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:MBIO)

Beware the Aussie Bullies

They are promoting broke companies like $MBIO and $SPAI. Stay away
MrForthright - 4 hours ago

The writing is on the wall

What today's news release left out is the game plan of Mindbio becoming Nazdaq listed through this deal with Enveric ... Mindbio...
Sleepydog24 - 3 days ago

RE:Why Would Enveric Do This?

This may be the "link" to MBIO I suggested in the first post. According to the Enveric website their next step for this...
Smokey1958 - 4 days ago

Why Would Enveric Do This?

The potential in this is extraordinary for both companies. I would expect that the reasons for Enteric entering into an agreement like...
Smokey1958 - 4 days ago

ENVERIC BIOSCIENCES SIGNS $66.5 MILLION

  Mindbio signs term sheet for Enveric psilocin prodrugs 2024-05-14 09:35 ET - News Release Shares issued 135,047,305 MBIO...
RocketRed777 - 4 days ago

Interim Financials MD&A

https://www.sedarplus.ca/csa-party/viewInstance/resource.html?node=W2713&drmKey=f15a810d73e220dc&drr...
Smokey1958 - 4 days ago
View more Bullboard ››

Fineqia International Inc.

Fineqia International Inc.

Fineqia is a digital asset business that builds and targets investments in early and growth-stage technology companies that ...
View More »